这项研究的目的是比较饮食态度,抑郁症状,身体活动水平,以及被诊断患有2019年冠状病毒病(COVID-19)的绝经后妇女和无绝经症状的妇女的绝经症状。本研究采用病例对照设计,包括137名绝经后妇女,病例组70名妇女,对照组67名妇女。病例组由所有在土耳其一家公立医院的COVID-19综合诊所注册的绝经后妇女组成,PCR结果阳性的人,至少一个月前被诊断出患有COVID-19。病例组中的每位妇女的年龄(±1岁)与因任何原因去过家庭健康中心且未怀疑或确认患有COVID-19疾病的对照组相匹配。数据是使用社会人口统计表格收集的,饮食态度测试,贝克抑郁量表,国际体育活动问卷简表,以及2021年1月27日至3月5日的更年期评定量表。统计分析包括百分比分布,算术平均值,标准偏差,独立组的t检验,卡方,Cronbach的阿尔法可靠性分析,二元逻辑回归分析,和协方差分析(ANCOVA)。结果显示,被诊断患有COVID-19的女性出现绝经后症状的风险是没有COVID-19的女性的1.36倍(OR=1.36,%95CI1.084-1.48,p<.001)。在为观察抑郁症状的影响而建立的ANCOVA模型中,被诊断患有COVID-19的女性与没有COVID-19的女性之间存在统计学上的显着差异(F=7.372,p<0.05),身体活动水平,通过消除吸烟的影响,对更年期症状的饮食态度,年龄和更年期激素治疗(MHT)的使用,它解释了4.2%的方差(2=.042)。这项研究表明,被诊断患有COVID-19的绝经后妇女经历了更多的更年期症状。建议卫生专业人员仔细评估被诊断患有COVID-19的绝经后妇女的更年期症状。
The purpose of this study is to compare the eatingt attitudes, depressive symptoms, physical activity levels, and menopausal symptoms of postmenopausal women who had been diagnosed with coronavirus disease 2019 (COVID-19) and women without. This study utilized a
case-control design and included 137 postmenopausal women, 70 women in the
case group and 67 women in the control group. The
case group was composed of all postmenopausal women who were registered in the COVID-19 polyclinic of a public hospital in Turkey, who had positive PCR results, and who had been diagnosed with COVID-19 at least one month before. Each woman in the
case group was matched by age (±1 year) with controls who visited the Family Health Center for any reason and who did not have suspected or confirmed COVID-19 disease. Data were collected using the Socio-demographic Form, the Eating Attitudes Test, the Beck Depression Inventory, the International Physical Activity Questionnaire-Short Form, and the Menopause Rating Scale between the 27th of January and the 5th of March 2021. Statistical analyses included percentage distributions, arithmetic means, standard deviation, t-test in independent groups, chi-square, Cronbach\'s alpha reliability analysis, binary logistic regression analysis, and analysis of covariance (ANCOVA). Results showed that women who had been diagnosed with COVID-19 had the risk of experiencing postmenopausal symptoms 1.36 times more than the women without (OR = 1.36 , %95 CI 1.084-1.48, p < .001). A statistically significant difference was found between women who had been diagnosed with COVID-19 and women without (F = 7.372, p < .05) in the ANCOVA model established to see the effect of depressive symptoms, physical activity levels, and eating attitudes on menopausal symptoms by eliminating the effects of smoking, age and menopause hormone therapy (MHT) use, and it explained 4.2% of the variance (Ƞ2 = .042). This study showed that postmenopausal women who had been diagnosed with COVID-19 experienced more menopausal symptoms. Health professionals are recommended to carefully evaluate the menopausal symptoms of postmenopausal women who had been diagnosed with COVID-19.